Navigation Links
First CyberKnife System Sold in Switzerland
Date:4/11/2008

dicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 40,000 patients worldwide and currently more than 125 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit http://www.accuray.com.

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, clinical studies, regulatory review and approval, and market acceptance and commercialization of products and services are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: market acceptance of products; competing products, the combination of our products with complementary technology; and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for the 2007 fiscal year, as updated from time to time by our quarterly reports on Form 10- Q and our other filings with the Secu
'/>"/>

SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Israel , September 2, 2015 ... intent of the National Institute of Allergy and Infectious Diseases ... within the Department of Health and Human Services (HHS), to ... the United States in the 2015-16 ... flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which ...
(Date:9/2/2015)... Diego, CA (PRWEB) , ... September 02, 2015 ... ... troubleshooting faults in manufacturing equipment, to creating professional commercial video content, to analysis ... detailed views of fascinating events that go by too quickly to process with ...
(Date:9/1/2015)... EDISON, N.J. , Sept. 1, 2015  ContraVir ... focused on the development and commercialization of targeted antiviral ... Rodman & Renshaw 17 th Annual Global Investment ... taking place September 8-10, 2015 at The St. Regis ... James Sapirstein , Chief Executive ...
(Date:9/1/2015)... ... 01, 2015 , ... VetStem Biopharma announces new Clinical Research ... problems can be caused by injuries and abnormalities of the cervical spine. Arthritic ... of the spinal cord itself. This can manifest itself as any or all ...
Breaking Biology Technology:BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 2VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 3
... MISSISSAUGA, ON, Aug. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... sciences product development company that identifies and advances a ... of development, today announced that its wholly-owned subsidiary, YM ... the US Department of the Treasury,s Office of Foreign ...
... ... in Cairo, Egypt. Amir Jahangir, Chief Executive Officer of SAMAA TV, delivered a talk ... Disease Outbreak at the World Health Organization,s Mediterranean Regional Office in Cairo, Egypt. ... Cairo, Egypt (PRWEB) ...
... effort to accelerate the scientific breakthroughs needed to build ... Chu announced the delivery of $377 million in funding ... located at universities, national laboratories, nonprofit organizations, and private ... global energy demand grows, there is an urgent need ...
Cached Biology Technology:YM BIOSCIENCES USA RECEIVES CLEARANCE FROM US TREASURY DEPARTMENT TO EXTEND CLINICAL PROGRAM FOR NIMOTUZUMAB 2YM BIOSCIENCES USA RECEIVES CLEARANCE FROM US TREASURY DEPARTMENT TO EXTEND CLINICAL PROGRAM FOR NIMOTUZUMAB 3YM BIOSCIENCES USA RECEIVES CLEARANCE FROM US TREASURY DEPARTMENT TO EXTEND CLINICAL PROGRAM FOR NIMOTUZUMAB 4Swine Flu (H1N1) can Become a Major Political Crisis Instead of a Health Crisis by October 2009, Amir Jahangir 2Swine Flu (H1N1) can Become a Major Political Crisis Instead of a Health Crisis by October 2009, Amir Jahangir 3Swine Flu (H1N1) can Become a Major Political Crisis Instead of a Health Crisis by October 2009, Amir Jahangir 4Swine Flu (H1N1) can Become a Major Political Crisis Instead of a Health Crisis by October 2009, Amir Jahangir 5DOE awards $377 million in funding for 46 energy frontier research centers 2DOE awards $377 million in funding for 46 energy frontier research centers 3DOE awards $377 million in funding for 46 energy frontier research centers 4
(Date:8/3/2015)... 3, 2015 Synaptics, Inc. (Nasdaq: SYNA ... announced that members of the executive management team will ... Global Technology Leadership Forum on Tuesday, August 11, 2015 ... held at the Sonnenalp Resort in Vail, ... include forward-looking information. An audio webcast of the event ...
(Date:7/31/2015)... , 31 de julio de 2015 BGI llevará ... www.icg-10.org ) del 22 al 25 de octubre de ... La conferencia celebra su décimo aniversario este año. ... en una de las reuniones anuales más influyentes del ... una de las conferencias científicas más dinámicas, entusiastas y ...
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... LIVERMORE, Calif. -- Using data derived from nuclear weapons ... have found that a small portion of the human ... adulthood. The research may have profound impacts on ... importance of investigating the therapeutic potential of applying adult ...
... Stephen J. Lippard, Ph.D., Arthur Amos Noyes Professor of ... editor of the Journal of the American Chemical ... the American Chemical Society (ACS). It is the highest ... ACS is honoring Lippard for "mentoring legions of scientists ...
... lives off everything it can metabolize into methane. How ... clear. Scientists at the Ruhr-Universitt Bochum together with colleagues ... a protein that might act as a "food sensor". ... similarities and differences to the system that is responsible ...
Cached Biology News:Weapons testing data determines brain makes new neurons into adulthood 2American Chemical Society's highest honor goes to Stephen J. Lippard, Ph.D. 2How Archaea might find their food 2
Identify and characterize Phosphoinositide (PI(4,5)P2) binding...
... These skirted micro test tubes are used ... polypropylene, these tubes have uniform walls for ... with separate O-ring screw caps. The O-rings ... have an operating range from -55 to ...
... Sac-Cel (Second Antibody Coated CELlulose) was developed ... of Dartford, Kent, one of the earliest ... IDS acquired the product range in 1987. ... clinical biochemists developing their own "in house" ...
Determine relative degree of protein binding to phosphoinositides...
Biology Products: